Volume | 461,248 |
|
|||||
News | - | ||||||
Day High | 25.23 | Low High |
|||||
Day Low | 24.22 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
24.69 | 24.22 | 25.23 | 25.15 | 24.66 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,206 | 461,248 | $ 24.96 | $ 11,513,593 | - | 13.72 - 33.34 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:32:51 | priorref | 85,700 | $ 25.15 | USD |
Protagonist Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.47B | 58.27M | - | 60M | -78.96M | -1.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protagonist Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 25.11 | 27.78 | 24.22 | 25.70 | 401,396 | 0.04 | 0.16% |
1 Month | 28.77 | 29.21 | 24.22 | 27.18 | 545,879 | -3.62 | -12.58% |
3 Months | 28.47 | 33.34 | 24.22 | 28.18 | 590,097 | -3.32 | -11.66% |
6 Months | 14.18 | 33.34 | 13.75 | 24.04 | 702,769 | 10.97 | 77.36% |
1 Year | 23.21 | 33.34 | 13.72 | 23.06 | 805,259 | 1.94 | 8.36% |
3 Years | 29.56 | 50.54 | 6.91 | 21.03 | 974,835 | -4.41 | -14.92% |
5 Years | 9.99 | 50.54 | 4.47 | 19.77 | 755,756 | 15.16 | 151.75% |
Protagonist Therapeutics Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. |